News items related to: News
-
Kenya Ratifies UAE Trade Deal Threatening Access to Affordable Medicines
Kenya has ratified a trade deal that undermines access to affordable medicines, weakens local production, and is “a direct assault on the constitutional right to health” according to MMA partner KELIN, who together with civil society groups and impacted communities, sought to strike clauses in the agreement which restrict and hinder public health.
-
MMA Partner Celebrates Milestone in Opposing Evergreening of TB Drug Patents in Vietnam
The Intellectual Property Office of Vietnam revoked claims 1-19, 21-23, and 25-32 by J&J, stating that J&J’s argument to patent...
-
Fundación GEP Marks Landmark Wins on Lenacapavir and Cabotegravir for Affordable HIV Prevention and Treatment in Argentina
The filing of oppositions is a fundamental strategic line of the FGEP’s Health Access Program, which allows the prevention and...
-
Activists Demand $40-a-year Generic Price for Breakthrough HIV Prevention Drug be Made Available to all Low- and Middle-Income Countries
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP...
-
Procurement Non-Transparency, Overreliance on Donors, and Lacking Political Will for Local Production: Recent Africa Market Intelligence Analysis
The reports, published by the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN – Kenya), Community Health...
-
ITPC Global Hosts Summit, Marking 30 years of Global Injustice
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit brought together over 100 activists, policymakers, and researchers...
-
Brazil’s ABIA Leads Fight Against Patent Barriers to HIV, TB and Other Life-Saving Medicines
Through its Working Group on Intellectual Property (GTPI), ABIA has filed more than 40 oppositions since 2006 against patents on...
-
New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention
Lenacapavir, administered just twice a year, has been shown to reduce HIV transmission to nearly zero. However, the drug’s high...
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...
-
GSIPA2M 2025 Highlights
Dive into three days of resistance, solidarity, and vision for the global fight for access to medicines. Click on the...
-
A Tribute to Courage and Justice: Honoring Professor Hakima Himmich at the GSIPA2M 2025
With emotion palpable in the air, Moroccan journalist Amine Boushaba opened the tribute by recalling his personal journey as an...
-
Marrakech to Host Critical Global Summit on Intellectual Property and Access to Medicines — TRIPS@30: The Access Crisis
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit takes place at a moment of historic urgency:...